crispr system and its applications in medicine and stem cell engineering

Context: the clustered regularly interspaced short palindromic repeat (crispr)/cas system is a groundbreaking gene-editing tool that shows great promise for modifying genomes. derived from prokaryotic adaptive immune defense mechanisms, this technique has been used in research on human diseases, demonstrating remarkable therapeutic potential. through crispr, specific genetic mutations in patients can be corrected during gene therapy, offering a solution for treating diseases that were previously untreatable using conventional methods. this review explores the recent progress and future prospects of the crispr system, focusing on its applications in medicine and stem cell engineering. special emphasis is placed on medical applications, the latest target design or analysis tools for genome editing, advancements in stem cell engineering, and associated innovations and challenges. evidence acquisition: this study reviewed articles indexed in isi, sid, pubmed, and pubmed central from 2007 to 2024. results: cas9, a key protein in crispr gene editing, is an endonuclease capable of targeting and cutting specific dna sequences, guided by short rna sequences. the gene editing process involves homology-directed repair (hdr), non-homologous end joining (nhej), and base editing pathways. base editing, which modifies the epigenome without inducing dna breaks, is gaining increasing attention. however, crispr still faces technical challenges, and the development of more efficient super crispr technology will likely require time. this article reviews the effectiveness, limitations, and applications of the crispr system. conclusions: crispr/cas9 tools allow for the creation of precise models, leading to more effective treatment options for patients.